tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market
MLYS
Mineralys Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see MLYS full AI Analyst Report?

Mineralys Therapeutics, Inc. (MLYS) Financial Statements

590 Followers

Mineralys Therapeutics, Inc. Financial Overview

Mineralys Therapeutics, Inc.'s market cap is currently $2.51B. The company's EPS TTM is $-0.4; its P/E ratio is -22.67; Mineralys Therapeutics, Inc. is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -59.00K$ -43.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -170.60M$ -192.40M$ -84.66M$ -31.48M$ -18.73M
EBITDA$ -170.60M$ -192.36M$ -84.66M$ -31.48M$ -19.38M
Net Income$ -154.65M$ -177.81M$ -71.90M$ -29.80M$ -19.41M
Balance Sheet
Cash & Short-Term Investments$ 656.63M$ 198.19M$ 236.57M$ 110.11M$ 10.61M
Total Assets$ 661.81M$ 205.90M$ 251.64M$ 114.44M$ 11.13M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -172.92M$ -114.09M$ -49.30M$ -87.70M$ -10.61M
Total Liabilities$ 15.11M$ 14.65M$ 10.48M$ 166.71M$ 34.05M
Stockholders' Equity$ 646.69M$ 191.26M$ 241.15M$ -52.27M$ -22.93M
Cash Flow
Free Cash Flow$ -142.43M$ -166.41M$ -81.17M$ -29.22M$ -14.56M
Operating Cash Flow$ -142.42M$ -166.31M$ -81.17M$ -29.22M$ -14.56M
Investing Cash Flow$ -389.75M$ 114.96M$ -160.47M$ -21.76M$ 0.00
Financing Cash Flow$ 591.00M$ 116.14M$ 203.25M$ 128.02M$ 23.81M
Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Mineralys Therapeutics, Inc. Debt to Assets

Balance Sheet >

Mineralys Therapeutics, Inc. Cash Flow

Cash Flow >

Mineralys Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >